Item Number: STELLAMO
Inactivated, Amphigen adjuvanted Mycoplasma hyopneumoniae vaccine.
An off-white emulsion for injection. Each 2ml dose of vaccine contains 4.5 to 5.2 log10 Relative Potency Units of inactivated Mycoplasma hyopneumoniae Strain NL1042, 0.025ml of Amphigen Base, and 0.075ml of Drakeol 5 (mineral oil).
For active immunisation of piglets from 7 days of age to reduce lung lesions related to infection by Mycoplasma hyopneumoniae in fattening pigs. The onset of immunity is within two weeks after vaccination. A duration of immunity of at least 25 weeks has been demonstrated.
In more detailed studies in piglets from three weeks of age, vaccination has also been shown to reduce coughing and losses in weight gain related to infection by Mycoplasma hyopneumoniae in fattening animals. In these studies, onset of immunity three weeks after vaccination and a duration of immunity of at least 23 weeks were demonstrated; periods shorter than three weeks of age or longer than 23 weeks were not tested.
Dosage and administration
Shake and aseptically administer a single 2ml injection by the deep intramuscular route in the lateral neck muscle.
One single dose of 2ml of vaccine should be given to piglets from 7 days of age. Vaccination should be performed prior to the period of risk. Infection usually occurs within the first month of life.
Contra-indications, warnings, etc
Do not vaccinate pregnant or lactating animals.
Hypersensitivity reactions, including shock and death may occur in very rare cases. Appropriate treatment (for example glucocorticoid intravenously or adrenaline intramuscularly) should be administered.
Administration of the vaccine may be followed by a mild, transient reaction at the injection site up to 2.5cm which resolves within two days (incidence 16%). Transient increases in rectal temperature can be observed for up to four days post vaccination.
As part of the immune reaction following vaccination, inflammatory cell infiltration and/or fibrosis may occur in the muscle tissue at the injection site, lasting for at least 14 days.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Injection site reactions observed after the administration of a single overdose are similar to those following a dose of vaccine. A percentage of animals (approximately 27%) vaccinated with an overdose may develop a palpable injection site reaction of up to 3cm in diameter that resolves within two days.
To the user
This product contains mineral oil.
Accidental injection/self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.
If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package insert with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician
This product contains mineral oil. Even if very small amounts have been injected, accidental injection with this oil-based product can cause intense swelling which may, for example, result in ischaemic necrosis and the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Store away from light between +2°C and +8°C. Do not freeze. A slight black deposit may appear during storage.
Shelf life after first opening the immediate packaging: 10 hours.
Do not mix with any other veterinary medical product.
Any unused product or waste material should be disposed of in accordance with national requirements.
STELLAMO: Data Sheet
There have been no questions/answers for this product so far.
There have been no reviews for this product.